HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful ...

Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient's lungs, legs, feet, and other parts of the body. The condition is chronic ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher ...

Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk ・Combines Mount Sinai’s world-class AI and ...

HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New ...

HeartBeam shares are trading higher Tuesday following a partnership with Mount Sinai to accelerate next-gen AI-ECG algorithms ...

HeartBeam CEO Robert Eno and CFO Timothy Cruickshank will attend the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, 2026. Management will host a presentation ...

Luka Doncic had 38 points and 11 assists, Austin Reaves added 29 points and the Los Angeles Lakers held off the Los Angeles ...

Recapping Day 12 of the 2026 Milan-Cortina Winter Olympics. Get the latest news, results, medal count, TV schedules and highlights from Italy.

HeartBeam, Inc. (BEAT) (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...